Orexigen Therapeutics Inc (NASDAQ:OREX)

5.01
Delayed Data
As of May 22
 +0.01 / +0.20%
Today’s Change
3.11
Today|||52-Week Range
9.37
-17.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues857.0K30.9M23.0M4.4M
 
 
 
 
 
Depreciation And Amortization38.0K41.0K52.0K--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses23.6M17.8M20.5M19.8M
 
 
 
 
 
Research And Development16.7M10.7M13.0M11.2M
 
 
 
 
 
Total Operating Expenses23.7M17.8M20.6M19.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.8M13.0M2.4M-15.5M
 
 
 
 
 
Interest Expense On Debt1.7M1.8M1.8M1.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.5M11.3M607.0K-17.2M
 
 
 
 
 
Net Income-24.5M11.3M607.0K-17.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS118.0M122.6M123.0M123.9M
 
 
 
 
 
Shares To Calculate EPS Diluted118.0M130.1M123.0M123.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.21$0.09$0.00-$0.14
 
 
 
 
EPS Diluted-$0.21$0.09$0.00-$0.14
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account